These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Combinations of drugs against Mycobacterium leprae studied in mice. Shepard CC Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383 [No Abstract] [Full Text] [Related]
24. Dapsone-resistant leprosy in a population of Bamako (Mali). Baquillon G; Ferracci C; Saint Andre P; Pattyn SR Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500 [No Abstract] [Full Text] [Related]
25. Drug susceptibility testing of Mycobacterium leprae. Baohong J Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):830-5. PubMed ID: 3325575 [No Abstract] [Full Text] [Related]
26. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
27. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae. Levy L; Shepard CC; Fasal P Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496 [No Abstract] [Full Text] [Related]
28. The treatment of leprosy with a new long-acting sulfonamide. Opromolla DV; Lopes CF; Sampaio SA Dermatol Int; 1968; 7(2):90-2. PubMed ID: 4911459 [No Abstract] [Full Text] [Related]
29. Primary dapsone-resistant leprosy in Cebu, Philippines. Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607 [TBL] [Abstract][Full Text] [Related]
30. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. Walker LL; Van Landingham RM; Shinnick TM Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of secondary dapsone resistance in Nepal. Samuel NM; Samuel S; Loudon J; Neupani K; Adiga RB Indian J Lepr; 1984; 56(4):823-7. PubMed ID: 6398344 [TBL] [Abstract][Full Text] [Related]
33. The death of Mycobacterium leprae during treatment with 4,4'-diaminodiphenylsulfone (DDS). Initial rate in patients. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1968 Sep; 17(5):769-75. PubMed ID: 4877714 [No Abstract] [Full Text] [Related]
34. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae. Pattyn SR Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832 [No Abstract] [Full Text] [Related]
36. Dapsone-resistant leprosy and its implications for leprosy control programmes. Pearson JM; Cap JA; Haile GS; Rees RJ Lepr Rev; 1977 Jun; 48(2):83-94. PubMed ID: 331000 [No Abstract] [Full Text] [Related]
37. The association of pregnancy and leprosy. II. Pregnancy in dapsone-resistant leprosy. Duncan ME; Pearson JM; Rees RJ Lepr Rev; 1981 Sep; 52(3):263-70. PubMed ID: 7035779 [No Abstract] [Full Text] [Related]
38. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene. Karat AB Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966 [No Abstract] [Full Text] [Related]
39. Ulcerating lepromatous leprosy in a patient with dapsone-resistant Mycobacterium leprae. McDougall AC; Rees RJ Lepr Rev; 1973 Jun; 44(2):59-64. PubMed ID: 4582180 [No Abstract] [Full Text] [Related]
40. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy. Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]